Oramed authorizes up to $20M stock buyback program over 12 months

ORAMED PHARMACEUTICALS INC.

Board authorized up to $20M in common stock repurchases, expiring in 12 months.
Repurchases may be on open market or private transactions under Rule 10b-18.
Program does not obligate purchase; can be terminated or modified by Board at any time.

item 8.01

ORAMED PHARMACEUTICALS INC. filing history →

Source: SEC EDGAR

accession 0001213900-24-055950

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.